Hydrazinecarboxamide, 2-(2-methylcyclohexylidene)- | 4549-20-6

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: Hydrazinecarboxamide, 2-(2-methylcyclohexylidene)-
• 英文别名: [(E)-(2-methylcyclohexylidene)amino]urea
• CAS: 4549-20-6
• 化学式: C₈H₁₅N₃O
• 分子量: 169.22
• InChiKey: ZOMWHULATAXVJE-JXMROGBWSA-N

物化性质

• 熔点：
  188-189.5 °C
• 密度：
  1.24±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.7
• 重原子数：
  12
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.75
• 拓扑面积：
  67.5
• 氢给体数：
  2
• 氢受体数：
  2

安全信息

• 海关编码：
  2928000090

文献信息

• Methods and compositions for treatment of cancer and autoimmune disease
  申请人：THE JACKSON LABORATORY

  公开号：US10207988B2

  公开（公告）日：2019-02-19

  The technology described herein relates to methods of inducing cell death. The technology described herein further relates to treating conditions including cancers and autoimmune diseases comprising administering inhibitors of double strand break repair. Also described herein are inhibitors of double strand break repair and methods of screening for such inhibitors.

  本文所述技术涉及诱导细胞死亡的方法。本文所述技术还涉及通过施用双链断裂修复抑制剂来治疗包括癌症和自身免疫性疾病在内的疾病。本文还描述了双链断裂修复抑制剂和筛选此类抑制剂的方法。
• METHODS AND COMPOSITIONS FOR TREATMENT OF CANCER AND AUTOIMMUNE DISEASE
  申请人：The Jackson Laboratory

  公开号：EP2724156A1

  公开（公告）日：2014-04-30
• EP2724156B1
  申请人：——

  公开号：EP2724156B1

  公开（公告）日：2017-08-16
• [EN] METHODS AND COMPOSITIONS FOR TREATMENT OF CANCER AND AUTOIMMUNE DISEASE<br/>[FR] PROCÉDÉS ET COMPOSITIONS POUR LE TRAITEMENT DU CANCER ET D'UNE MALADIE AUTO-IMMUNE
  申请人：JACKSON LAB

  公开号：WO2013003112A1

  公开（公告）日：2013-01-03

  The technology described herein relates to methods of inducing cell death. The technology described herein further relates to treating conditions including cancers and autoimmune diseases comprising administering inhibitors of double strand break repair. Also described herein are inhibitors of double strand break repair and methods of screening for such inhibitors.